Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Assessment of peak inspiratory flow in patients with chronic obstructive pulmonary disease : a multicentre, observational, prospective, real-life study
Authors:ID Perugini, Valeria (Author)
ID Rhee, Chin Kook (Author)
ID Moon, Ji-Yong (Author)
ID Yee, Tiew Pei (Author)
ID Ra, Seung Won (Author)
ID Pirina, Pietro (Author)
ID Harlander, Matevž (Author)
Files:.pdf PDF - Presentation file, download (819,54 KB)
MD5: 8B90A749FFBF8B44A9164D150536075A
 
URL URL - Source URL, visit https://bmjopenrespres.bmj.com/content/12/1/e002408
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Introduction: Patients with chronic obstructive pulmonary disease (COPD) use dry powder inhalers (DPIs) for disease management. DPI effectiveness relies on the patient’s peak inspiratory flow (PIF), which may not always be optimal. We conducted an observational multicentre, prospective, real-life cohort study to determine the prevalence of suboptimal PIF in patients with COPD. Methods: 415 participants (11%, n=47 women, mean age=70±8.7 years, mean forced expiratory volume in 1 s (predicted %)=48.1%) recruited from 17 international centres had baseline PIF recorded with an In-Check Dial device at three resistance levels: (1) low, (2) high and (3) the participant’s maintenance device. We also recorded PIF from participants as they would do at home to verify their proper inhalation technique. Participants underwent spirometry and completed questionnaires (COPD Assessment Test (CAT), Test of Adherence to Inhalers (TAI)-12). Results: Of the 415 participants, 18% of DPI users (n=75) exhibited suboptimal values of PIF (as typical PIF <than what was required for tested inhalers in the study) when evaluated across DPI resistance groups ranging from low (R1) to high (R5) resistance, compared with 14% of participants (n=60) using devices without resistance (R0). Additionally, 14% of study participants were incapable of producing an optimal PIF or unwilling to do so (27%), impacting medication effectiveness. Participants with suboptimal PIF values had higher mean total CAT score (17.7±7) compared with those with optimal PIF values (12.1±7.6). When assessed globally, 37% (n=56) of participants with suboptimal PIF values did not adhere to treatment, highlighting the need for improved patient education and support. Conclusion: Suboptimal PIF is common in COPD, requiring regular assessment and tailored inhalers.
Keywords:chronic obstructive pulmonary disease, COPD, peak inspiratory flow, dry powder inhaler, inhaler devices, inhaler therapy, tailor treatment plans
Publication status:Published
Publication version:Version of Record
Year of publishing:2025
Number of pages:str. 1-10
Numbering:Vol. 12, iss. 1, [article no.] e002408
PID:20.500.12556/DiRROS-24893 New window
UDC:616.2
ISSN on article:2052-4439
DOI:10.1136/bmjresp-2024-002408 New window
COBISS.SI-ID:250524675 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 26. 9. 2025;
Publication date in DiRROS:23.12.2025
Views:8
Downloads:5
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:BMJ open respiratory research
Shortened title:BMJ open respir. res.
Publisher:BMJ in partnership with the British Thoracic Society
ISSN:2052-4439
COBISS.SI-ID:523010073 New window

Document is financed by a project

Funder:Other - Other funder or multiple funders
Project number:Study No. 1237-0103
Name:Boehringer Ingelheim (BI) International GmbH

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Back